Sepsis in immunocompromised hosts

Journal of the Royal College of Physicians of London

Volumn 34, Issue 6, 2000, Pages 533-536

  Conlon, Christopher ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTEREMIA; BONE MARROW TRANSPLANTATION; GRAFT VERSUS HOST REACTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFECTION RISK; MYCOSIS; REVIEW; SEPSIS;

BONE MARROW TRANSPLANTATION; FUNGEMIA; GRAFT VS HOST DISEASE; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; NEOPLASMS; RISK FACTORS; SEPSIS;

EID: 0034521504     PISSN: 00358819     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Holdsworth RJ, Irving AD, Cuschieri A. Post-splenectomy sepsis and its mortality rate: actual versus perceived risks. Br J Surg 1991;78:1031-8.
2. Rubio M, Palau L, Vivas JR, del Potro E, et al. Predominance of Gram-positive microorganisms as a cause of septicemia in patients with hematological malignancies. Review. Infect Control Hosp Epidemiol 1994;15:101-4.
3. Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis 1990; 161:381-96.
4. Wingard JR, Merz WG, Rinaldi MG, Miller CB, et al. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991;325:1274-7.
5. EORTC International Antimicrobial Therapy Cooperative Group. Empiric antifungal therapy in febrile granulocytopenic patients. Am J Med 1989;86: 668-72.
6. Walsh TJ, Finberg RW, Arndt C, Hiemenz J, et al. Liposomal amphotericin B for empiric therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. N Engl J Med 1999;340:764-71.
7. Ochs L, Shu XO, Miller J, Enright H, et al. Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients. Review. Blood 1995;86:3979-86.
8. Merigan TC, Renlund DG, Keay S, Bristow MR, et al. A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. N Engl J Med 1992;326:1182-6.
9. van der Horst CM, Saag MS, Cloud GA, Hamill RJ, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med 1997;337:15-21.
10. Redd SC, Rutherford GW 3d, Sande MA, Lifson AR, et al. The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J Infect Dis 1990;162: 1012-7.
11. Gruenewald R, Blum S, Chan J. Relationship between human immunodeficiency virus infection and salmonellosis in 20-to 59-year-old residents of New York City. Clin Infect Dis 1994;18:358-63.
12. Fichtenbaum CJ, Dunagan WC, Powderly WG. Serious Pseudomonas aeruginosa infections in patients infected with human immunodeficiency virus: a case-control study. Clin Infect Dis 1994;19: 417-22.